Skip to Main Content

Paper Details

Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines.
Cancer Discov
2
2023
Activated T cells, Atg5, Cancer, IFN, MHC, MHC class I, MHC class I (MHC, MHC-I, MHC-I-deficient cancer cells, MHC-I-deficient tumor cells, Resistant Cancer Cells, Rnf31, T cells, TNF, Tumor, Tumors, apoptotic MHC-I-deficient tumor cells, cancer, dendritic cells, producing T cells, sensitized, sensitized MHC-I-deficient tumor cells, tumor, tumor cells, tumors
Author NameAffiliation
Deng PanDana-Farber Cancer Institute
Deng PanHarvard Medical School
John G DoenchBroad Institute of MIT and Harvard
Xiaole Shirley LiuDana-Farber Cancer Institute
  • 1 - 4

Datasets

Release 1.2